Dolby Laboratories (DLB) Receivables - Other (2018 - 2026)

Dolby Laboratories has reported Receivables - Other for 9 years, with the latest figure at $238.9 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other rose 61.22% year-over-year to $238.9 million; the trailing twelve-month figure through Mar 2026 stood at $238.9 million (up 61.22% YoY), and the FY2025 full-year result was $180.8 million, up 4.03% from the prior year.
• Receivables - Other for Q1 2026 stood at $238.9 million, up from $198.3 million in the prior quarter.
• The five-year high for Receivables - Other was $258.8 million in Q2 2022, with the low at $106.9 million in Q3 2022.
• Historically, Receivables - Other has averaged $163.5 million across 5 years, with a median of $150.4 million in 2023.
• Annual changes were most pronounced in 2023 — Receivables - Other slumped 54.41% — and 2024, when it surged 66.21%.
• Dolby Laboratories' Receivables - Other stood at $111.9 million in 2022, then rose by 18.77% to $132.9 million in 2023, then soared by 66.21% to $220.9 million in 2024, then declined by 10.24% to $198.3 million in 2025, then increased by 20.51% to $238.9 million in 2026.
• The last three Receivables - Other figures came in at $238.9 million (Q1 2026), $198.3 million (Q4 2025), and $180.8 million (Q3 2025), per Business Quant data.